Evidence map›Paper›PMID 36258713›Full record

ArticleInternational journal of MCH and AIDS2022

Factors Impacting Vaccine Uptake during Pregnancy: A Retrospective Analysis.

Maame Aba Coleman, Deepa Dongarwar, Jessica Ramirez, Mei-Li Laracuente, Chelsea Livingston, Julliet Ogu, Racquel Lyn, Arabella Hall, Sylvia Adu-Gyamfi, Hamisu M Salihu

Open access · goldAbstract read
In one paragraph

Article in International journal of MCH and AIDS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maame Aba ColemanDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
Deepa DongarwarCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Jessica RamirezCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Mei-Li LaracuenteCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Chelsea LivingstonCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Julliet OguCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Racquel LynCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Arabella HallCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Sylvia Adu-GyamfiCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Hamisu M SalihuCenter of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
Baylor College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Vaccine uptake rates during pregnancy remain below target goals due to a convergence of factors. In particular, women of lower socioeconomic means and racial minorities typically have reduced rates of vaccine acceptance. This study aims to identify additional factors contributing to vaccine acceptance within a sample population of women receiving prenatal care in Houston, Texas, United States of America. Methods: We performed a retrospective cross-sectional analysis of 11,500 pregnant women covered by Medicaid or ChipPerinate who received prenatal care during 2013-2021, assessing influenza (flu) and combined Tetanus, Diphtheria, Acellular Pertussis (TDAP) vaccine acceptance in the patient population. We examined temporal trends in flu and TDAP vaccination rates using Joinpoint regression analyses and evaluated the factors associated with single or concomitant vaccine acceptance during the study period and during the COVID-19 pandemic using adjusted log-binomial regression models. Results: In our population, 54% of patients received flu vaccination, and 76.1% received TDAP. TDAP rates increased from 2013-2015 but have shown an overall decline since then, as with the flu vaccine. Earlier entry to prenatal care (Prevalence Ratio [PR] 6.32; Confidence Interval [CI] 3.28-12.24) and pregnancy comorbidity such as gestational diabetes (PR 1.32; CI 0.82-2.19) were positively associated with uptake. In contrast, the NH-Black race was negatively associated with vaccine acceptance (PR 0.51 CI; 0.25-0.99). Otherwise, age and history of pre-pregnancy comorbidities were not significant predictors. Conclusion and Global Health Implications: Within demographic groups identified as at-risk for vaccine refusal, modifying factors further impact vaccine hesitancy. Identifying these elements will guide targeted patient efforts to promote vaccine uptake, both for routine prenatal recommendations and for COVID vaccination.

Indexed as

COVID-19FluPatient CommunicationTDAPVaccination in PregnancyVaccine Hesitancy in Pregnancy

Identifiers

PMID36258713
PMCPMC9551120
OpenAlexW4295102024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.